kinase inhibitors (Sphaera/Cardero)

N/A

Report date: 2025/03/20 15:12:08
NME

Base Information

Drug Namekinase inhibitors (Sphaera/Cardero)
Drug Alias Namecardiovascular drugs (Sphaera/Cardero)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsMetabolic SyndromeCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSphaera Pharma
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMetabolic SyndromeCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A